| P50 | author | Carlo Nucci | Q67168288 |
| P2093 | author name string | Giacinto Bagetta | |
| | Luigi Antonio Morrone | |
| | Mauro Maccarrone | |
| | Monica Bari | |
| | Arnoldo Spanò | |
| | MariaTiziana Corasaniti | |
| P2860 | cites work | Identification and cloning of three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain | Q22001491 |
| | Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain | Q24299523 |
| | Brain monoglyceride lipase participating in endocannabinoid inactivation | Q24533828 |
| | GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current | Q24653442 |
| | Molecular characterization of a phospholipase D generating anandamide and its congeners | Q28186509 |
| | CB1 cannabinoid receptors and on-demand defense against excitotoxicity | Q28207143 |
| | Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons | Q28245016 |
| | In silico patent searching reveals a new cannabinoid receptor | Q28284495 |
| | The molecular logic of endocannabinoid signalling | Q29615356 |
| | International Union of Pharmacology. XXVII. Classification of cannabinoid receptors | Q29616832 |
| | Formation and inactivation of endogenous cannabinoid anandamide in central neurons | Q29620558 |
| | Effect of WIN 55212-2, a cannabinoid receptor agonist, on aqueous humor dynamics in monkeys | Q30881082 |
| | Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial | Q31113402 |
| | Efficacy and safety of memantine treatment for reduction of changes associated with experimental glaucoma in monkey, II: Structural measures | Q33205224 |
| | Endothelin B receptor in human glaucoma and experimentally induced optic nerve damage. | Q33242789 |
| | Neuroprotection in relation to retinal ischemia and relevance to glaucoma | Q33693575 |
| | The toxic effect of sodium L-glutamate on the inner layers of the retina. | Q33969485 |
| | Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure. | Q34072766 |
| | An endogenous cannabinoid (2-AG) is neuroprotective after brain injury | Q34093755 |
| | N-Acylethanolamines and precursor phospholipids - relation to cell injury | Q34098995 |
| | The therapeutic potential of cannabis | Q34212503 |
| | Cannabinoid physiology and pharmacology: 30 years of progress. | Q34355485 |
| | Molecular characterization of N-acylethanolamine-hydrolyzing acid amidase, a novel member of the choloylglycine hydrolase family with structural and functional similarity to acid ceramidase | Q34385277 |
| | Prevention of Alzheimer's disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. | Q34397288 |
| | The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies | Q34513181 |
| | A second fatty acid amide hydrolase with variable distribution among placental mammals | Q34570802 |
| | Cannabinoid receptors and their ligands | Q34673022 |
| | Functions of cannabinoid receptors in the hippocampus | Q34750566 |
| | Cannabinoids and neuroinflammation | Q35046205 |
| | Possible role for memantine in protecting retinal ganglion cells from glaucomatous damage | Q35174032 |
| | Increased plasma endothelin-1 levels in patients with progressive open angle glaucoma | Q35592811 |
| | Retinal ischemia: mechanisms of damage and potential therapeutic strategies | Q35650660 |
| | Cannabinoids and glaucoma | Q35748271 |
| | Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite | Q35843412 |
| | Cannabinoids and neuroprotection in CNS inflammatory disease | Q36127875 |
| | Structure and function of fatty acid amide hydrolase | Q36161171 |
| | Activation of CB1 cannabinoid receptors inhibits neurotransmitter release from identified synaptic sites in rat hippocampal cultures | Q73457865 |
| | Metabolism of anandamide, an endogenous cannabinoid receptor ligand, in porcine ocular tissues | Q73562118 |
| | Effects of topical alpha-substituted anandamides on intraocular pressure in normotensive rabbits | Q74131027 |
| | Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia | Q77510870 |
| | Marijuana smoking vs cannabinoids for glaucoma therapy | Q77583123 |
| | Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits | Q77674840 |
| | Anandamide inhibits endothelin-1 production by human cultured endothelial cells: a new vascular action of this endocannabinoid | Q79370475 |
| | Primary open-angle glaucoma | Q80122027 |
| | Cannabinoid agonist WIN 55212-2 speeds up the cone response to light offset in goldfish retina | Q83200961 |
| | Noladin ether acts on trabecular meshwork cannabinoid (CB1) receptors to enhance aqueous humor outflow facility | Q83201977 |
| | Histologic changes in the inner retina of albino rats following intravitreal injection of monosodium L-glutamate | Q93647550 |
| | Cannabinoid receptors and their role in neuroprotection | Q36211444 |
| | Endocannabinoid metabolic pathways and enzymes | Q36352186 |
| | The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases | Q36727554 |
| | Biochemistry and pharmacology of endovanilloids | Q36756199 |
| | The (endo)cannabinoid system in multiple sclerosis and amyotrophic lateral sclerosis | Q36902277 |
| | Topical WIN55212-2 alleviates intraocular hypertension in rats through a CB1 receptor mediated mechanism of action | Q37086961 |
| | Activity-based protein profiling: from enzyme chemistry to proteomic chemistry | Q37119021 |
| | Dronabinol and retinal hemodynamics in humans | Q39779600 |
| | Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells | Q40070777 |
| | Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells. | Q40224855 |
| | The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism | Q40817229 |
| | Molecular basis of glutamate toxicity in retinal ganglion cells. | Q40873212 |
| | Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum | Q42523780 |
| | R(+)-methanandamide and other cannabinoids induce the expression of cyclooxygenase-2 and matrix metalloproteinases in human nonpigmented ciliary epithelial cells | Q42674843 |
| | Cannabinoid agonists induce relaxation in the bovine ophthalmic artery: evidences for CB1 receptors, nitric oxide and potassium channels | Q43038421 |
| | Effects of topical anandamide-transport inhibitors, AM404 and olvanil, on intraocular pressure in normotensive rabbits. | Q43672168 |
| | Interaction between delta-9-tetrahydrocannabinol and indomethacin | Q43682118 |
| | Cannabinoids and brain injury: therapeutic implications | Q43869210 |
| | Vitreous amino acid concentrations in patients with glaucoma undergoing vitrectomy. | Q44313042 |
| | Presynaptic Facilitation of Glutamatergic Synapses to Dopaminergic Neurons of the Rat Substantia Nigra by Endogenous Stimulation of Vanilloid Receptors | Q44418969 |
| | Cannabinoids inhibit neurodegeneration in models of multiple sclerosis | Q44522438 |
| | Chronic topical administration of WIN-55-212-2 maintains a reduction in IOP in a rat glaucoma model without adverse effects | Q44915044 |
| | Vanilloid receptor like 1 (VRL1) immunoreactivity in mammalian retina: colocalization with somatostatin and purinergic P2X1 receptors | Q44918609 |
| | Vitreous and retinal amino acid concentrations in experimental central retinal artery occlusion in the primate | Q44927514 |
| | Cannabinoid agonists induce contractile responses through Gi/o-dependent activation of phospholipase C in the bovine ciliary muscle | Q44934399 |
| | Molecular basis for species-specific sensitivity to "hot" chili peppers | Q45712451 |
| | Finding of endocannabinoids in human eye tissues: implications for glaucoma | Q46432377 |
| | Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease | Q46443478 |
| | Reciprocal inhibition of voltage-gated potassium currents (I K(V)) by activation of cannabinoid CB1 and dopamine D1 receptors in ON bipolar cells of goldfish retina | Q46447396 |
| | Neurochemical evidence to implicate elevated glutamate in the mechanisms of high intraocular pressure (IOP)-induced retinal ganglion cell death in rat. | Q46673234 |
| | Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide. | Q46936833 |
| | Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17beta-estradiol | Q48089296 |
| | Delta9-tetrahydrocannabinol acts as a partial agonist to modulate glutamatergic synaptic transmission between rat hippocampal neurons in culture | Q48309181 |
| | Delta9-tetrahydrocannabinol protects hippocampal neurons from excitotoxicity | Q48350622 |
| | The cannabinoid agonist Win55,212-2 inhibits calcium channels by receptor-mediated and direct pathways in cultured rat hippocampal neurons | Q48482096 |
| | Glutamate release in experimental ischaemia of the retina: an approach using microdialysis | Q51688785 |
| | The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. | Q53872479 |
| | Effect of sublingual application of cannabinoids on intraocular pressure: a pilot study. | Q55042467 |
| | Biosynthesis and Inactivation of N-Arachidonoylethanolamine (Anandamide) and N-Docosahexaenoylethanolamine in Bovine Retina | Q60690628 |
| | Neuroprotective and Intraocular Pressure-Lowering Effects of (–)Δ 9 -Tetrahydrocannabinol in a Rat Model of Glaucoma | Q61053086 |
| | Involvement of the Endocannabinoid System in Retinal Damage after High Intraocular Pressure–Induced Ischemia in Rats | Q61896991 |
| | Retinal Damage Caused by High Intraocular Pressure–Induced Transient Ischemia is Prevented by Coenzyme Q10 in Rat | Q61897001 |
| | Marihuana Smoking and Intraocular Pressure | Q64962468 |
| | Multiple-drop study of topically applied 1% delta 9-tetrahydrocannabinol in human eyes | Q67283147 |
| | Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma | Q70999763 |
| | Effects of topical anandamides on intraocular pressure in normotensive rabbits | Q71094610 |
| | The release of amino acids from ischemic retina | Q73399303 |
| P921 | main subject | cannabinoids | Q422936 |
| P304 | page(s) | 451-464 | |
| P577 | publication date | 2008-01-01 | |
| P1433 | published in | Progress in Brain Research | Q15800382 |
| P1476 | title | Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection | |
| P478 | volume | 173 | |